Mycobacterium Tuberculosis Global Market Report 2025
상품코드:1760639
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
결핵균 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 5.2%의 CAGR로 45억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 전 세계 결핵 유병률 증가, 약제 내성 결핵 발생률 증가, 결핵 감염 및 예방에 대한 인식 증가, 결핵 퇴치를 위한 정부의 노력과 자금 지원, 결핵 치료에 초점을 맞춘 연구 및 개발 증가 등이 견인할 것으로 예상됩니다. 예측 기간 동안 주요 동향으로는 결핵 진단 기술의 발전, 신속한 결핵 검사법의 가용성, 새로운 결핵 백신의 도입, 다제내성 결핵에 대한 새로운 약물 요법 개발, 결핵 약물 제제의 기술 혁신 등이 있습니다.
결핵균 시장의 성장은 연구개발에 대한 투자 증가에 의해 견인될 것으로 예상됩니다. 연구개발(R&D)은 체계적인 연구와 실험을 통해 새로운 지식을 창출하거나 기존 제품, 서비스, 기술을 개선하는 것을 포함합니다. R&D 투자의 증가는 급속한 기술 발전에 힘입어 세계 시장에서 경쟁력을 유지하기 위한 끊임없는 혁신의 필요성을 낳고 있습니다. R&D는 현재 치료법에 대한 내성을 극복할 수 있는 신약 후보를 발견함으로써 치료 효과와 환자 결과를 개선하고 결핵 치료에 기여합니다. 예를 들어, 2024년 3월 영국 정부는 중저소득 국가들의 결핵 진단 및 치료 개선을 위한 혁신적인 전략을 지원하기 위해 결핵 REACH 프로그램에 500만 달러(400만 파운드)를 지원한다고 발표했습니다. 이 프로그램을 통해 50만 명에게 의료 서비스를 제공하고, 3만 7,000명의 결핵을 발견하고, 1만 5,000명 이상의 생명을 구할 수 있을 것으로 기대됩니다. 이에 따라 연구개발에 대한 투자가 증가하여 결핵균 시장의 성장을 견인할 것입니다.
결핵균 시장의 각 기업들은 보다 신속하고 정확한 진단을 제공하기 위해 자동 결핵 검사와 같은 첨단 솔루션 개발에 주력하고 있습니다. 자동화된 결핵 검사는 자동화된 시스템과 첨단 기술을 사용하여 결핵균과 약제 내성을 신속하고 정확하게 검출하고 사람의 개입을 최소화하는 진단 도구입니다. 예를 들어, 2025년 4월 미국 생명공학 기업 Revvity Inc.는 미국 식품의약국(FDA)이 AutoPure 2400 액체 취급 플랫폼과 T-SPOT 결핵 검사를 승인했다고 발표했습니다. AutoPure 2400 플랫폼과 T-SPOT.TB 검사의 통합은 정확성을 유지하면서 대량 처리를 가능하게함으로써 자동 결핵 검사를 개선합니다. 이 플랫폼은 액체 처리 기술과 자기 세포 분리 기술을 결합하여 한 번의 검사로 최대 24개의 검체를 검사할 수 있으며, 검사 1일차를 3.5시간 이내에 완료하고 사용자의 개입을 최소화할 수 있습니다. IGRA로 인정받고 있으며, 불확실한 결과가 적고 재현성 있는 결과를 보장하여 재검사의 필요성을 줄이고, 면역부전 환자에게 신뢰할 수 있는 성능을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 결핵균 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 결핵균 시장 : 성장률 분석
세계의 결핵균 시장 규모·성장률 : 실적치, 2019-2024년
세계의 결핵균 시장 규모·성장률 : 예측치, 2024-2029년, 2034년
세계의 결핵균 시장 : 총유효과 시장(TAM)
제6장 시장 세분화
세계의 결핵균 시장 : 제품 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
장비
시약·소모품
소프트웨어 솔루션
세계의 결핵균 시장 : 진단법별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
배양 기반 진단법
분자진단
면역학적 검사
세계의 결핵균 시장 : 투여 경로별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
경구제
주사제
세계의 결핵균 시장 : 최종사용자별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
병원
진단 검사실
연구기관
세계의 결핵균 시장 : 장비 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
진단 기기
검출 기기
분자진단 기기
결핵 배양 시스템
세계의 결핵균 시장 : 시약·소모품 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
중합효소 연쇄 반응 시약(PCR)
결핵 배양 배지
항원 키트
테스트 스트립
결핵 진단 키트
세계의 결핵균 시장 : 소프트웨어 솔루션 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
검사 정보 관리 시스템(LIMS)
진단 소프트웨어
데이터 관리 소프트웨어
결핵 진단을 위한 원격의료 솔루션
제7장 지역별·국가별 분석
세계의 결핵균 시장 : 지역별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
세계의 결핵균 시장 : 국가별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
결핵균 시장 : 경쟁 구도
결핵균 시장 : 기업 개요
F. Hoffmann-La Roche Ltd.(개요, 제품 및 서비스, 전략, 재무 분석)
Thermo Fisher Scientific Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
Abbott Laboratories(개요, 제품 및 서비스, 전략, 재무 분석)
Novartis AG(개요, 제품 및 서비스, 전략, 재무 분석)
Becton Dickinson and Company(개요, 제품 및 서비스, 전략, 재무 분석)
제31장 기타 주요 기업과 혁신적 기업
Viatris Inc.
Macleods Pharmaceuticals Limited
bioMerieux SA
Bio-Rad Laboratories Inc.
Bruker Corporation
QIAGEN N.V.
Lupin Limited
Zydus Cadila Healthcare Limited
Cepheid Inc.
Serum Institute of India Pvt. Ltd.
Oxford Immunotec USA Inc.
Panacea Biotec Limited
International AIDS Vaccine Initiative Inc.
HiMedia Laboratories Private Limited
Akonni Biosystems Inc.
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업 인수합병(M&A)
제34장 최근의 시장 동향
제35장 시장 잠재력 높은 나라·부문과 전략
결핵균 시장 : 최신 기회를 제공하는 국가(2029년)
결핵균 시장 : 최신 기회를 제공하는 부문(2029년)
결핵균 시장 : 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Mycobacterium tuberculosis is a slow-growing, rod-shaped bacterium that primarily targets the lungs, although it can also affect other body parts. It is the pathogen responsible for tuberculosis (TB), a contagious disease transmitted through airborne droplets when an infected person coughs, sneezes, or speaks. The bacterium has a distinct, waxy cell wall made of mycolic acid, which provides resistance to drying and helps it persist in the environment.
The primary product types associated with Mycobacterium tuberculosis include instruments, reagents and consumables, and software solutions. Instruments refer to the medical devices and equipment used for diagnosing and researching TB. Diagnosis can be achieved through various techniques, such as culture-based methods, molecular testing, and immunological assays, with administration routes being either oral or injectable. These products are used by various end users, including hospitals, diagnostic labs, and research institutions.
The mycobacterium tuberculosis market research report is one of a series of new reports from The Business Research Company that provides mycobacterium tuberculosis market statistics, including mycobacterium tuberculosis industry global market size, regional shares, competitors with a mycobacterium tuberculosis market share, detailed mycobacterium tuberculosis market segments, market trends and opportunities, and any further data you may need to thrive in the mycobacterium tuberculosis industry. This mycobacterium tuberculosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The mycobacterium tuberculosis market size has grown strongly in recent years. It will grow from $3.54 billion in 2024 to $3.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to the rising number of TB cases in high-burden countries, increased funding from international organizations, the expansion of TB screening programs, a higher incidence of TB-HIV co-infections, and the growth in global travel and migration, which have contributed to the spread of TB.
The mycobacterium tuberculosis market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth during the forecast period is expected to be driven by the increasing prevalence of TB worldwide, the rising global incidence of drug-resistant TB, heightened awareness about TB transmission and prevention, government initiatives and funding for TB elimination, and increased research and development efforts focused on TB treatment. Key trends in the forecast period include advances in TB diagnostic technologies, the availability of rapid TB testing methods, the introduction of new TB vaccines, the development of new drug regimens for multidrug-resistant TB, and technological innovations in TB drug formulation.
The growth of the mycobacterium tuberculosis market is expected to be driven by increased investments in research and development. Research and development (R&D) involves the creation of new knowledge or the improvement of existing products, services, or technologies through systematic investigation and experimentation. The rising investment in R&D is fueled by rapid technological advancements, creating the need for constant innovation to remain competitive in the global market. R&D contributes to mycobacterium tuberculosis treatment by discovering novel drug candidates capable of overcoming resistance to current therapies, thus enhancing treatment efficacy and patient outcomes. For example, in March 2024, the UK government announced a $5 million (£4 million) funding boost for the TB REACH program, aimed at supporting innovative strategies for improving tuberculosis diagnosis and treatment in low- and middle-income countries. This initiative will provide healthcare to 500,000 people, help detect TB in 37,000 individuals, and potentially save more than 15,000 lives. As a result, the increased investment in R&D is set to drive the growth of the mycobacterium tuberculosis market.
Companies in the mycobacterium tuberculosis market are focusing on developing advanced solutions such as automated tuberculosis tests to provide faster, more accurate diagnoses. Automated tuberculosis tests are diagnostic tools that use automated systems and advanced technologies to rapidly and accurately detect Mycobacterium tuberculosis and drug resistance, with minimal human intervention. For instance, in April 2025, Revvity Inc., a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) approved the Auto-Pure 2400 liquid handling platform with the T-SPOT TB test. The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test improves automated tuberculosis testing by enabling higher-volume processing while maintaining accuracy. This platform combines liquid handling and magnetic cell isolation technologies, testing up to 24 samples per run, completing Day 1 of testing in under 3.5 hours, and requiring minimal user involvement. The T-SPOT.TB test, recognized by the WHO as the only ELISPOT-based IGRA, ensures reproducible results with fewer indeterminate outcomes, reduces the need for repeat testing, and provides reliable performance for immunocompromised patients.
In November 2023, Becton Dickinson and Company (BD), a US-based provider of tuberculosis diagnostics, collaborated with Bio Farma to help Indonesia eliminate the spread of tuberculosis. This partnership aims to enhance access to BD's innovative TB diagnostics portfolio and improve the TB solutions supply chain in Indonesia. It also offers Bio Farma the opportunity to deepen its expertise in the development of diagnostic kits. Bio Farma is an Indonesia-based manufacturer of tuberculosis vaccines.
Major players in the mycobacterium tuberculosis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Macleods Pharmaceuticals Limited, bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Lupin Limited, Zydus Cadila Healthcare Limited, Cepheid Inc., Serum Institute of India Pvt. Ltd., Oxford Immunotec USA Inc., Panacea Biotec Limited, International AIDS Vaccine Initiative Inc., HiMedia Laboratories Private Limited, and Akonni Biosystems Inc.
North America was the largest region in the mycobacterium tuberculosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mycobacterium tuberculosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the mycobacterium tuberculosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The mycobacterium tuberculosis market consists of revenues earned by entities by providing services such as tuberculosis strain typing and genotyping services, contract research services, biorepository services, and genomic sequencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The mycobacterium tuberculosis market also includes sales of diagnostic kits, antibodies, antigens, recombinant proteins, nucleic acid extraction kits, and biosafety equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mycobacterium Tuberculosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mycobacterium tuberculosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for mycobacterium tuberculosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mycobacterium tuberculosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software Solutions
2) By Diagnostic Method: Culture-Based Methods; Molecular Diagnosis; Immunological Tests
3) By Route Of Administration: Oral; Injectable
4) By End User: Hospitals; Diagnostic Laboratories; Research Institutions
Subsegments:
1) By Instruments: Diagnostic Instruments; Detection Instruments; Molecular Diagnostic Instruments; Tuberculosis Culture Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Reagents; Tuberculosis Culture Media; Antigen Kits; Test Strips; Tuberculosis Diagnostic Kits
3) By Software Solutions: Laboratory Information Management Systems (LIMS); Diagnostic Software; Data Management Software; Telemedicine Solutions for TB Diagnosis
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG; Becton Dickinson and Company
3. Mycobacterium Tuberculosis Market Trends And Strategies
4. Mycobacterium Tuberculosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Mycobacterium Tuberculosis Growth Analysis And Strategic Analysis Framework
5.1. Global Mycobacterium Tuberculosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Mycobacterium Tuberculosis Market Growth Rate Analysis
5.4. Global Mycobacterium Tuberculosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Mycobacterium Tuberculosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Mycobacterium Tuberculosis Total Addressable Market (TAM)
6. Mycobacterium Tuberculosis Market Segmentation
6.1. Global Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents And Consumables
Software Solutions
6.2. Global Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Culture-Based Methods
Molecular Diagnosis
Immunological Tests
6.3. Global Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
6.4. Global Mycobacterium Tuberculosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Research Institutions
6.5. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Instruments
Detection Instruments
Molecular Diagnostic Instruments
Tuberculosis Culture Systems
6.6. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction Reagents
Tuberculosis Culture Media
Antigen Kits
Test Strips
Tuberculosis Diagnostic Kits
6.7. Global Mycobacterium Tuberculosis Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Information Management Systems (LIMS)
Diagnostic Software
Data Management Software
Telemedicine Solutions for TB Diagnosis
7. Mycobacterium Tuberculosis Market Regional And Country Analysis
7.1. Global Mycobacterium Tuberculosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Mycobacterium Tuberculosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Mycobacterium Tuberculosis Market
9.1. China Mycobacterium Tuberculosis Market Overview
9.2. China Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Mycobacterium Tuberculosis Market
10.1. India Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Mycobacterium Tuberculosis Market
11.1. Japan Mycobacterium Tuberculosis Market Overview
11.2. Japan Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Mycobacterium Tuberculosis Market
12.1. Australia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Mycobacterium Tuberculosis Market
13.1. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Mycobacterium Tuberculosis Market
14.1. South Korea Mycobacterium Tuberculosis Market Overview
14.2. South Korea Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Mycobacterium Tuberculosis Market
15.1. Western Europe Mycobacterium Tuberculosis Market Overview
15.2. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Mycobacterium Tuberculosis Market
16.1. UK Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Mycobacterium Tuberculosis Market
17.1. Germany Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Mycobacterium Tuberculosis Market
18.1. France Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Mycobacterium Tuberculosis Market
19.1. Italy Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Mycobacterium Tuberculosis Market
20.1. Spain Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Mycobacterium Tuberculosis Market
21.1. Eastern Europe Mycobacterium Tuberculosis Market Overview
21.2. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Mycobacterium Tuberculosis Market
22.1. Russia Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Mycobacterium Tuberculosis Market
23.1. North America Mycobacterium Tuberculosis Market Overview
23.2. North America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Mycobacterium Tuberculosis Market
24.1. USA Mycobacterium Tuberculosis Market Overview
24.2. USA Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Mycobacterium Tuberculosis Market
26.1. South America Mycobacterium Tuberculosis Market Overview
26.2. South America Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Mycobacterium Tuberculosis Market
27.1. Brazil Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Mycobacterium Tuberculosis Market
28.1. Middle East Mycobacterium Tuberculosis Market Overview
28.2. Middle East Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Mycobacterium Tuberculosis Market
29.1. Africa Mycobacterium Tuberculosis Market Overview
29.2. Africa Mycobacterium Tuberculosis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Mycobacterium Tuberculosis Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Mycobacterium Tuberculosis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Mycobacterium Tuberculosis Market Competitive Landscape And Company Profiles
